ITGAL and neoplasm: As PD-L1 is the inhibitory ligand, we next examined expression of the inhibitory receptor, PD-1, by CD4+ and CD8+ tumor-associated T cells (gating-Supplemental Figure 2D) all of which are also positive for CD11a, a molecule that has been shown to render them unable to control tumor growth (50).